These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36457129)

  • 1. Machine learning and experimental validation to construct a metastasis-related gene signature and ceRNA network for predicting osteosarcoma prognosis.
    Liao Y; Liu Q; Xiao C; Zhou J
    J Orthop Surg Res; 2022 Dec; 17(1):516. PubMed ID: 36457129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

  • 3. The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer.
    Shang C; Li Y; He T; Liao Y; Du Q; Wang P; Qiao J; Guo H
    J Adv Res; 2022 Mar; 37():169-184. PubMed ID: 35499057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
    Li G; Lei J; Xu D; Yu W; Bai J; Wu G
    Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA FER1L4 Suppresses Tumorigenesis by Regulating the Expression of PTEN Targeting miR-18a-5p in Osteosarcoma.
    Fei D; Zhang X; Liu J; Tan L; Xing J; Zhao D; Zhang Y
    Cell Physiol Biochem; 2018; 51(3):1364-1375. PubMed ID: 30481787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and experimental validation of hypoxia-related gene signatures for osteosarcoma diagnosis and prognosis based on WGCNA and machine learning.
    Wen B; Chen J; Ding T; Mao Z; Jin R; Wang Y; Shi M; Zhao L; Yang A; Qin X; Chen X
    Sci Rep; 2024 Aug; 14(1):18734. PubMed ID: 39134603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
    Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
    Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
    Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
    Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Analysis of Competing Endogenous RNAs Network Reveals Potential Signatures in Osteosarcoma Development.
    Heng L; Jia Z; Sun J; Zhao Y; Zhang K; Zhu Y; Lu S
    Technol Cancer Res Treat; 2020; 19():1533033820957025. PubMed ID: 32912111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
    Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
    Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Development of a Novel 4-Gene Immune-Related Signature to Predict Osteosarcoma Prognosis.
    Cao M; Zhang J; Xu H; Lin Z; Chang H; Wang Y; Huang X; Chen X; Wang H; Song Y
    Front Mol Biosci; 2020; 7():608368. PubMed ID: 33425993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel vasculogenic mimicry-associated gene signature for the prognostic assessment of osteosarcoma patients.
    Yan L; Li R; Li D; Zhu Y; Lv Z; Wang B
    Clin Transl Oncol; 2023 Dec; 25(12):3501-3518. PubMed ID: 37219824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis and validation of mesenchymal stem cells related gene MT1G in osteosarcoma.
    Zheng S; Cheng X; Ke S; Zhang L; Wu H; He D; Cheng X
    Aging (Albany NY); 2024 May; 16(9):8155-8170. PubMed ID: 38747739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic signature related to programmed cell death in osteosarcoma.
    Jiang YC; Xu QT; Wang HB; Ren SY; Zhang Y
    Front Immunol; 2024; 15():1427661. PubMed ID: 39015570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis.
    Lian H; Xie P; Yin N; Zhang J; Zhang X; Li J; Zhang C
    Life Sci; 2019 Sep; 233():116757. PubMed ID: 31419446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
    Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
    Front Oncol; 2021; 11():640150. PubMed ID: 33869028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
    Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
    J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature.
    Zhong Y; Zhang Y; Wei S; Chen J; Zhong C; Cai W; Jin W; Peng H
    Front Endocrinol (Lausanne); 2022; 13():1030655. PubMed ID: 36313783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glycometabolic gene signature associating with immune infiltration and chemosensitivity and predicting the prognosis of patients with osteosarcoma.
    Wang F; Yang K; Pan R; Xiang Y; Xiong Z; Li P; Li K; Sun H
    Front Med (Lausanne); 2023; 10():1115759. PubMed ID: 37293295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.